e-Drug3D

66

SULFISOXAZOLE ACETYL

DISCONTINUED


INN
SULFISOXAZOLE ACETYL

(has an active metabolite)

cas 80-74-0
CLASS

ANTIINFECTIVES
ANTIBACTERIAL
TREATMENT OF URINARY TRACT INFECTIONS
SULFONAMIDES

ROUTE (list)

ORAL

ATC code

J01EB05
S01AB02

PK parameters

Solubility

PRACTICALLY INSOLUBLE IN WATER


Target

TARGET DIHYDROPTEROATE SYNTHASE

DrugCentral

Dihydropteroate synthase UNIPROT P0AC13 folP

Download SDF file Acetamide, N-[(4-aminophenyl)sulfonyl]-N-(3,4-dimethyl-5-isoxazolyl)-

Formula:
C13H15N3O4S

Calculated chemical properties:

MW 309.35
NB_atoms 21
XLogP 1.62
PSA 97.548
NB_HD 2
NB_HA 7
fsp3 0.23
Lipinski(0=no;1=yes) 1

FDA
NDA 050599 (pdf not found) INN (ERYTHROMYCIN ESTOLATE ; SULFISOXAZOLE ACETYL) ILOSONE SULFA (LILLY) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 009182 (pdf not found) INN (SULFISOXAZOLE ACETYL) GANTRISIN (ROCHE) APPROVAL= AP YEAR= 1953 DISCONTINUED
NDA 050529 (pdf not found) INN (ERYTHROMYCIN ETHYLSUCCINATE ; SULFISOXAZOLE ACETYL) PEDIAZOLE (ROSS LABS) APPROVAL= AP YEAR= 1979 DISCONTINUED
NDA 062758 (pdf not found) INN (ERYTHROMYCIN ETHYLSUCCINATE ; SULFISOXAZOLE ACETYL) ERYZOLE (ALRA) APPROVAL= AP YEAR= 1988 DISCONTINUED
NDA 062759 (pdf not found) INN (ERYTHROMYCIN ETHYLSUCCINATE ; SULFISOXAZOLE ACETYL) ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL (BARR) APPROVAL= AP YEAR= 1988 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL